fda bpc-157 safety risks compounding Targets GLP-1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling Regeneration or Risk? A Narrative
Description
Anything less leaves the door open to research labs, resellers, and grey-market suppliers
A larger group of compounded peptides sits in regulatory limbo with thin clinical evidence
It is also used to treat cyanide poisoning, as it binds to cyanide molecules and helps to detoxify them
This occurs both inside and outside the blood vessels of the gastrointestinal tract, presenting a wide range of potential uses
It represents a specific C-terminal region of growth hormone, allowing researchers to study isolated functional domains rather than the entire hormone
